A New Era
For the physician-scientists at Johns Hopkins, a new era in pancreatic cancer treatment is coming.
They are focused on research into immunotherapy, vaccines, and treatments targeting RAS, which are changing outcomes. The ultimate goal: preventing pancreatic cancer, especially in those at high risk.
Recent Stories
Patient Voices
September 22, 2026 • 10 Min
One Year Later
Research
September 17, 2026 • 6 Min
A New Approach to MEK Inhibition for First-Line Treatment
Survivor Stories
September 11, 2026 • 2 Min
